Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report
East Asian Archives of Psychiatry · 2018
DOI: 10.12809/eaap181706 ↗At a glance
Fallbericht in East Asian Archives of Psychiatry, 2018. Cited 1 times so far (Crossref). The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Clozapine is considered to be more effective than other antipsychotic drugs for treating treatmentresistant schizophrenia. However, side effects of clozapine include agranulocytosis and, less commonly, cardiovascular disease, which is occasionally fatal. We describe a 56-year-old woman who developed clozapine-related paroxysmal supraventricular tachycardia during clozapine dose titration and had a recurrence despite being treated with verapamil. For treatment-resistant schizophrenia, a slow titration of the clozapine dose is necessary, and potential cardiac side-effects should be monitored.
Cite
APA
(2018). Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report. East Asian Archives of Psychiatry. https://doi.org/10.12809/eaap181706
Vancouver
Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report. East Asian Archives of Psychiatry. 2018. doi:10.12809/eaap181706
BibTeX
@article{euvimed2018,
title = {Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report},
journal = {East Asian Archives of Psychiatry},
year = {2018},
doi = {10.12809/eaap181706}
}
EUVIMED